Researchers have new hope for HIV vaccine
UC infectious disease expert is featured guest on WVXU
Carl Fichtenbaum, MD, vice chair for clinical research in internal medicine in the University of Cincinnati College of Medicine and renowned HIV expert, recently appeared on WVXU radio's Cincinnati Edition program to talk about the new hope of developing an HIV vaccine.
Though a vaccine is likely still years away, a new injection therapy given several times a year is a game changer, he said.
"HIV should be just a part of the same, general discussions we have about having a healthy lifetime. We don't do that enough. We need to do it more," Fichtenbaum said.
Listen to the full episode online.
Featured image at top of HIV cell: Courtesy of National Institutes of Health
Related Stories
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
Pennsylvania news: Personalized treatment for deadly blood and bone marrow cancer
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
Medical News Today: Gene mutation may be a key to lung cancer treatment
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.